Similar articles

Abstract: Objective: To investigate the relationship between the expression of endothelial nitric oxide synthase (eNOS), vascular endothelial growth factor (VEGF) and angiogenesis in primary astrocytoma. Methods: Thirty-seven primary astrocytomas and 4 astrocytic hyperplasia samples were collected and divided into three groups according to histological grade. The expression of eNOS, VEGF and factor VIII related antigen (FVIIIRAg) were assayed by immunohistochemistry. Microvascular density was assessed by FVIIIRAg immunoreactivity. The intensity of immunoreactivity was graded according to the percentage of positive tumor cells. Results: No eNOS and VEGF were expressed in the astrocytes and vascular endothelium in astrocytic hyperplasia. The expression of eNOS or VEGF was light in low-grade astrocytoma and strong in glioblastoma. eNOS expression in astrocytoma was very positively correlated with VEGF. eNOS and VEGF expression in anaplastic astrocytoma was median in contrast to the low grade astrocytoma and glioblastoma. Lower microvascular density was found in low grade astrocytoma than that in higher grade malignant ones. The expressions of eNOS and VEGF were correlated with microvascular density and tumor malignancy. Conclusion: This finding suggests that eNOS and VEGF may have cooperative effect in tumor angiogenesis and play an important role in the pathogenesis of primary astrocytoma.

[1] Bian, X.W., Du, L.L., Shi, J.Q., Cheng, Y.S., Liu, F.X., 2000. Correlation of bFGF, FGFR and VEGF expression with vascularity and malignancy of human astrocytomas. Anal Quant Cytol Histol, 22(3):267-274.

[2] Bouloumie, A., Schini-Kerth, V.B., Busse, R., 1999. Vascular endothelial growth factor up-regulates nitric oxide synthase expression in endothelial cells. Cardiovasc Res, 41(3):773-780.

[3] Fukumura, D., Gohongi, T., Kadambi, A., Izumi, Y., Ang, J., Yun, C.O., Buerk, D.G., Huang, P.L., Jain, R.K., 2001. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA, 98(5):2604-2609.

[4] Fulton, D., Gratton, J.P., McCabe, T.J., Fontana, J., Fujio, Y., Walsh, K., Franke, T.F., Papapetropoulos, A., Sessa, W.C., 1999. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature, 399(6736):597-601.

[5] Iwata, S., Nakagawa, K., Harada, H., Oka, Y., Kumon, Y., Sakaki, S., 1999. Endothelial nitric oxide synthase expression in tumor vasculature is correlated with malignancy in human supratentorial astrocytic tumors. Neurosurgery, 45(1):24-28.

[6] Kimura, H., Weisz, A., Kurashima, Y., Hashimoto, K., Ogura, T., D’Acquisto, F., Addeo, R., Makuuchi, M., Esumi, H., 2000. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: Control of hypoxia-inducible factor-1 activity by nitric oxide. Blood, 95(1):189-197.

[7] Koistinen, P., Siitonen, T., Mantymaa, P., Koistinen, P., Siitonen, T., Mantymaa, P., Saily, M., Kinnula, V., Savolainen, E.R., Soini, Y., 2001. Regulation of the acute myeloid leukemia cell line OCI/AML-2 by endothelial nitric oxide synthase under the control of a vascular endothelial growth factor signaling system. Leukemia, 15(9):1433-1441.

[8] Ludwig, H.C., Feiz-Erfan, I., Bockermann, V., Behnke-Mursch, J., Schallock, K., Markakis, E., 2000. Expression of nitric oxide synthase isoenzymes (NOS I−III) by immunohistochemistry and DNA in situ hybridization: Correlation with macrophage presence, vascular endothellial growth factor (VEGF) and edema volumetric data in 220 glioblastomas. Anticancer Res, 20(1A):299-304.

[9] Morales-Ruiz, M., Fulton, D., Sowa, G., Languino, L.R., Fujio, Y., Walsh, K., Sessa, W.C., 2000. Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt. Circ Res, 86(8):892-896.

[10] Murohara, T., Asahara, T., Silver, M., Bauters, C., Masuda, H., Kalka, C., Kearney, M., Chen, D., Symes, J.F., Fishman, M.C., Huang, P.L., Isner, J.M., 1998. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest, 101(11):2567-2578.

[11] Nishikawa, R., Cheng, S.Y., Nagashima, R., 1998. Expression of vascular endothelial growth factor in human brain tumors. Acta Neuropathol(Berl), 96(5):453-462.

[12] Percy, C., Van-Holten, V., Muir, C., 1990. International Classification of Diseases for Oncology. Second Edition, World Health Organization, Geneva, p.M938-M948

[13] Phillips, P.G., Birnby, L.M., Narendran, A., Milonovich, W.L., 2001. Nitric oxide modulates capillary formation at the endothelial cell-tumor cell interface. Am J Physiol Lung Cell Mol Physiol, 281(1):L278-L290.

[14] Swaroop, G.R., Kelly, P.A., Bell, H.S., Shinoda, J., Yamaguchi, S., Whittle, I.R., 2000. The effects of chronic nitric oxide synthase suppression on glioma pathophysiology. Br J Neurosurg, 14(6):543-548.

[15] Wang, B., Xiong, Q., Shi, Q., Tan, K., Le, X., Xie, K., 2001. Genetic disruption of host nitric oxide synthase II gene impairs melanoma-induced angiogenesis and suppresses pleural effusion. Int J Cancer, 91(5):607-611.

[16] Zachary, I., Gliki, G., 2001. Signaling transduction mechanisms mediating biological action of the vascular endothelial growth factor family. Cardiovasc Res, 49(3):568-581.

[17] Zhang, M., Pan, J.W., Ren, T.R., Zhu, Y.F., Han, Y.J., Kühnel, W., 2003. Correlated expression of inducible nitric oxide synthase and P53, Bax in benign and malignant diseased gallbladder. Ann Anat, 185(6):549-554.

[18] Ziche, M., Morbidelli, L., 2000. Nitric oxide and angiogenesis. J Neurooncol, 50(1-2):139-148.